M
Myron S. Cohen
Researcher at University of North Carolina at Chapel Hill
Publications - 576
Citations - 50913
Myron S. Cohen is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 103, co-authored 549 publications receiving 46021 citations. Previous affiliations of Myron S. Cohen include University of Massachusetts Medical School & Scripps Health.
Papers
More filters
Journal ArticleDOI
Impact of early-stage HIV transmission on treatment as prevention
TL;DR: A mathematical model is used to address the question: Does the proportion of transmission during early HIV infection affect the impact of HIV treatment on HIV incidence?
Journal ArticleDOI
Successful treatment of HIV eliminates sexual transmission.
TL;DR: The investigators concluded that the risk of HIV transmission from an HIV-infected man receiving ART with a plasma HIV-1 RNA (viral load) of less than 200 copies per mL over the preceding year was, remarkably, zero, with a narrow upper 95% CI limit of 0·23 per 100 couple-years of follow-up.
Journal ArticleDOI
The Use of Specimens from Various Genitourinary Sites in Men, to Detect Trichomonas vaginalis Infection
S. Cornelia Kaydos-Daniels,William C. Miller,Irving F. Hoffman,Matthew Price,Francis Martinson,David Chilongozi,David Namakwha,Syze Gama,Seveliano Phakati,Myron S. Cohen,Marcia M. Hobbs +10 more
TL;DR: Semen was the most sensitive single specimen, and, in 25.6% of cases, only semen specimens tested positive, suggesting that prevalence of T. vaginalis infection in men is underestimated if only 1 specimen is tested.
Posted ContentDOI
Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention
Meagan P. O'Brien,Eduardo Forleo Neto,Bret J Musser,Flonza Isa,Kuo-Chen Chan,Neena Sarkar,Katharine J. Bar,Ruanne V. Barnabas,Dan H. Barouch,Myron S. Cohen,Christopher B. Hurt,Dale R. Burwen,Mary A. Marovich,Peijie Hou,Ingeborg Heirman,John D. Davis,Kenneth C. Turner,Divya Ramesh,Adnan Mahmood,Andrea T. Hooper,Jennifer D. Hamilton,Yunji Kim,Lisa A. Purcell,Alina Baum,Christos A. Kyratsous,James Krainson,Richard Perez-Perez,Rizwana Mohseni,Bari Kowal,A. Thomas DiCioccio,Neil Stahl,Leah Lipsch,Ned Braunstein,Gary Herman,George D. Yancopoulos,David M. Weinreich +35 more
TL;DR: In this article, the authors explored the possibility that subcutaneous REGEN-COV could prevent SARS-CoV-2 infection and subsequent Covid-19 in individuals at high risk of contracting SARS CoV2 by close exposure in a household with a documented SARS coV-infected individual.
Journal ArticleDOI
Effect of modification of cytochrome c on its reactions with superoxide and NADPH:cytochrome P-450 reductase.
TL;DR: Acetylation and succinylation of cytochrome c decrease its rate of reaction with superoxide, and forms the quantitative basis for the enhanced specificity of modified cy tochrome c for superoxide detection previously described by other investigators.